Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a mul
Strickler, John H (author);Cercek, Andrea (author);Siena, Salvatore (author);André, Thierry (author);Ng, Kimmie (author);Van Cutsem, Eric (author);Wu, Christina (author);Paulson, Andrew S (author);Hubbard, Joleen M (author);Coveler, Andrew L (author);Foun
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a mul
Strickler, John H (author);Cercek, Andrea (author);Siena, Salvatore (author);André, Thierry (author);Ng, Kimmie (author);Van Cutsem, Eric (author);Wu, Christina (author);Paulson, Andrew S (author);Hubbard, Joleen M (author);Coveler, Andrew L (author);Foun
★ 5.0
·
36 reads
- Request Code
- ZLIB.IO18523972
- Published
- 2022
- Publisher
- Elsevier BV
- Pages
- 1
- Language
- English
- Format
- PDF PAGES: